share_log

A Closer Look at 4 Analyst Recommendations For PROCEPT BioRobotics

A Closer Look at 4 Analyst Recommendations For PROCEPT BioRobotics

关于PROCEPt BioRobotics,有4位分析师做出以下推荐:
Benzinga ·  07/16 16:01
4 analysts have expressed a variety of opinions on PROCEPT BioRobotics (NASDAQ:PRCT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中,有4位分析师对Procept BioRobotics(纳斯达克股票代码:PRCT)表达了不同的看法,从看涨到看跌,提出了各种各样的观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估,说明了过去30天不断变化的情绪,并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for PROCEPT BioRobotics, presenting an average target of $75.25, a high estimate of $79.00, and a low estimate of $72.00. Surpassing the previous average price target of $66.75, the current average has increased by 12.73%.
在评估12个月目标股价时,分析师公布了对Procept BioRobotics的见解,将平均目标价定为75.25美元,最高估计为79.00美元,低估值为72.00美元。超过了之前的平均目标股价66.75美元,目前的平均价格上涨了12.73%。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级:深度探索
The standing of PROCEPT...
通过对近...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发